The providers at the CPC are active in a variety of research activities. Please see our Recent Activities including presentations, publications, and grant research; as well as our current Clinical Trials and Study Opportunities
Research Study Opportunities- Clinical Trials
A new OHSU study examines how one’s thoughts affect pain and the immune system
Participation involves 3 hours of your time and blood draw. You will be guided to focus on the negative aspects of your pain condition for 10 minutes. Your body’s response to these negative thoughts will be measured over the next 2.5 hours. We are enrolling persons from the Comprehensive Pain Center between the ages of 18 and 65 with chronic musculoskeletal pain.
Participants receive $100 cash
Please call Dr. Beth Darnall at 503.577.8377 for details.
Complex Regional Pain Syndrome Type 1 (CRPS)
(also known as Reflex Sympathetic Dystrophy RSD)
The OHSU Comprehensive Pain Center is looking for CRPS sufferers to participate in a research study to test an investigational drug for the treatment of CRPS in people 18 years or older.
CRPS is a type of nerve pain involving an arm or leg. People with CRPS often feel that the entire extremity is painful and may note changes in temperature, color, sweating, skin, or nails. CRPS often starts with a relatively minor injury.
You will be seen at OHSU seven times during the first 14 weeks of the study (pre-treatment/treatment phase) and periodically during the optional extension phase. During the treatment phase, you will have a 50/50 chance of receiving either the study drug or a placebo. During the extension phase, everyone will receive the study drug. All study procedures, supplies, exams, and lab work are provided at no cost.
Qualified participants will receive payments of $10.00 per completed visit up to 21 visits.
eIRB#231
Principal Investigator: Brett R. Stacey, MD
OHSU Comprehensive Pain Center OP-26
3181 SW Sam Jackson Park Road, Portland, OR 97239
Contact Kathy 503.494.5223 for more information.
Recent Completed Research Activity
Brett Stacey
Brett Stacey is also the PI for a new clinical trial regarding Lyrica. The trial will seek to evaluate the time to the onset of meaningful pain relief in subjects with pain associated with PHN treated with either pregabalin 150 - 600mg/day, 300mg/day or placebo. Meaningful pain relief is defined as a decrease of 30% or more in the weekly mean score that is sustained until the end of the treatment. The study also aims to determine whether decreases in pain are associated with a better quality of life. Individual subject involvement is approximately 6 weeks during which time they fill out daily pain and sleep diaries that follow their progress.
Brett Stacey is also the PI for a new clinical trial for the treatment of Complex Regional Pain Syndrome.
RECENT and UPCOMING PRESENTATIONS
Brett Stacey MD
"Complex Regional Pain Syndrome and Neuropathic Pain"
December 9, 2005
OHSU Hand Conference, Portland, OR
Poster Presentation "Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy (DPN) and Post-Herpetic Neuralgia (PHN) in Treatment Refractory Patients: Findings From a Long-Term Open-Label Trial of Pregabalin"
November 3-5, 2005
8th International Conference on the Mechanisms and Treatment of Neuropathic Pain
San Francisco, CA
"Extracting Meaning from Clinical Trials"
October 18, 2005
Clinical Research-in-Progress Seminar
OHSU Dept of Anesthesiology & Peri-Operative Medicine
Portland, OR
"Pre-emptive Analgesia" and "Use of Opioids in Chronic Pain"
September 20, 2005
Western Neurosurgical Society Pain Symposium
Squaw Creek, CA
"Neuropathic Pain: Overview and Treatment Options"
August 25, 2005
Veterans Administration Medical Center
Portland, OR
David Sibell MD
"Successful Use of Spinal Cord Stimulation in the Treatment of Severe Raynaud's Disease of the Hands" Poster Presentation
American Society of Regional Anesthesia (ASRA) Annual Meeting
Phoenix, Arizona
November 2004
RECENT PUBLICATIONS
David Sibell
David Sibell (Ed.), "The Five Minute Pain Consult". (c) 2007
